Norovirus outbreak infected over 240 people on month-long luxury cruise
On Apr. 2, 2025, Cunard announced a norovirus outbreak had occurred aboard a luxury cruise ship that struck…
Norovirus cases are surging in parts of the U.S.
On Dec. 28, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that cases of a…
Biotechnology | HIV | Infectious Disease | Medicine | Vaccine | WHO
WHO study lists top endemic pathogens for which new vaccines are urgently needed
On Nov. 5, 2024, a World Health Organization (WHO) study published in eBioMedicine named 17 pathogens that regularly…
Cocrystal Pharma’s COVID-19 oral and intranasal/pulmonary protease inhibitors exhibited powerful in vitro potency against the SARS-CoV-2 Omicron variant
On Dec. 22, 2021, Cocrystal Pharma announced that in vitro studies demonstrate its oral and intranasal/pulmonary SARS-CoV-2 main…
Cocrystal Pharma’s SARS-CoV-2 protease inhibitors ddemonstrated pan-viral activity against human common Coronaviruses, Noroviruses, Rhinoviruses and Enteroviruses
On Nov. 8, 2021, Cocrystal Pharma announced that its SARS-CoV-2 main protease inhibitors showed potent in vitro pan-viral…
Vaxart reported boosting immune responses in subjects previously vaccinated by a Vaxart vaccine
On Jul. 29, 2021, Vaxart announced that it has shown for the first time in clinical trials that…
Vaxart announced publication that showed potential clinical and economic value of a Norovirus vaccine
On Jan. 27, 2021, Vaxart announced that health care economic findings published in the American Journal of Preventative…